BCI Marketplace
Deep Brain Stimulation trials

Cognitive Decline Following Deep Brain Stimulation: A DBS-fMRI Study

RecruitingNCT06960096Phase: Not specifiedStarted 2025-08-21

Summary

The objective of this research study is to understand how Deep Brain Stimulation (DBS) targeting the subthalamic nucleus (STN) affects cognitive networks in the brain, potentially leading to cognitive decline in patients with Parkinson's Disease (PD). A total of 55 participants with PD who have undergone DBS surgery will be recruited from MUSC's Clinical DBS Program. Participants will attend two post-DBS visits: a 3-hour visit for consent, demographic, and cognitive assessments, and a 3-hour DBS

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
None

Inclusion Criteria: * Subjects above 18 years of age * Individuals with a PD diagnosis as defined by the UK Brain Bank diagnostic criteria for Parkinson's disease (58) which have undergone a neurological and neuropsychological evaluation at MUSCs movement disorder center, and were selected to under

Locations

Medical University of South Carolina
Charleston, South Carolina, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →